Products with Anti-platelet aggregation bioactivity
| Cat.No. | Product Name |
|---|---|
| BCN3375 | Cyclocommunol |
| 1. Cyclocommunol exhibits cytotoxicity against hepatocellular carcinoma (SMMC-7721) and gastric carcinoma (BGC-823 and SGC-7901) cell lines. 2. Cyclocommunol shows strong inhibition of arachidonic acid (AA)- and collagen-induced platelet aggregation. | |
| BCN3382 | Gnetol |
| 1. Gnetol has a strong inhibitory effect on murine tyrosinase activity. 2. Gnetol significantly suppresses melanin biosynthesis in murine B16 melanoma cells. 3. Gnetol has the IC(50) value of 1.3 uM towards butyrylcholinesterase and shows a reversible and competitive inhibition in the kinetic study. 4. Gnetol is active in the inhibition of arachidonic acid (AA)-induced platelet aggregation. | |
| BCN3388 | Kazinol A |
| 1. Kazinol A shows strong inhibition of arachidonic acid (AA)-induced platelet aggregation. 2. Kazinol A possesses potent antioxidant activity against 2,2-diphenyl-l-picrylhydrazyl and 2,2′-azino-bis-ethylbenzthiazoline-6-sulfonic acid (ABTS) radicals. | |
| BCN3470 | (+)-Pteryxin |
| (+)-Pteryxin has muscle-relaxant props, it also shows hepatoprotective and nitric oxide prodn. inhibitory activity. | |
| BCN3552 | Ginsenoside Rk1 |
| Ginsenoside Rk1, one of the main elements of Sung Ginseng, has been confirmed as a new endothelial barrier enhancer recently and has anti-cancer activity, the mechanism involves coordination between inhibition of telomerase activity and induction of apoptosis. | |
